Blue Note Therapeutics Funding: $31M Raised, Series A (2021)
Blue Note Therapeutics is based in San Francisco. It has raised $31M in total funding. Latest round: Series A.
Blue Note Therapeutics funding overview
Blue Note Therapeutics is based in San Francisco. Blue Note Therapeutics has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2021. The round record for Blue Note Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include JAZZ Venture Partners, Summer VC, Memorial Sloan - Kettering Cancer Center, Alumni Ventures. 4 distinct backers are named across the disclosed rounds.
Blue Note Therapeutics at a glance
Total raised
$31M
Latest round
Series A
Latest round date
March 2021
Headquarters
San Francisco
Notable investors
JAZZ Venture Partners, Summer VC, Memorial Sloan - Kettering Cancer Center, Alumni Ventures
Frequently asked about Blue Note Therapeutics funding
How much has Blue Note Therapeutics raised?
Blue Note Therapeutics has raised $31M in total disclosed funding across the rounds on record.
Who has invested in Blue Note Therapeutics?
JAZZ Venture Partners, Summer VC, Memorial Sloan - Kettering Cancer Center, Alumni Ventures are named among the investors backing Blue Note Therapeutics.
What was the latest Blue Note Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2021.
Where is Blue Note Therapeutics based?
Blue Note Therapeutics is based in San Francisco.
When did Blue Note Therapeutics last raise?
The last disclosed Blue Note Therapeutics round closed in March 2021 at Series A.
Every Blue Note Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco at a similar stage.
